Back

prof. dr. G.D. Valk

Full Professor

  • Department of Endrocine Oncology

prof. dr. G.D. Valk

Research Programs

Biography

Endocrinology and endocrine oncology are the main focus of the clinical activities of Gerlof Valk. (Neuro-) endocrine tumors diagnosis, treatment and follow-up, care for patients with Multiple Endocrine Neoplasia (MEN) and the standardization and continuous improvement of the national care for patients with MEN are his specific areas of expertise. Epidemiologic and translational research within the field of MEN related (pancreatic) neuroendocrine tumors is his main research focus including innovative treatment strategies and personalized cancer care.

 

ACADEMIC APPOINTMENTS

2014 – today 

Internist-endocrinologist, professor of endocrinology with emphasis on endocrine tumors, head of section endocrinology, program director endocrinology residency

 

2007 – 2014  

Internist-endocrinologist, vice program director internal medicine residency

 

1997 – 2001  

Senior researcher, Institute for Extramural Medical Research (EMGO Institute), Free University Medical Centre

 

DIPLOMAS AND CERTIFICATION

2007 Certification National Board of Internal Medicine and Endocrinology

2002 MSc Clinical Epidemiology

1997 PhD Thesis: ‘The diagnosing of diabetic polyneuropathy in daily clinical practice’. Free University Medical Centre, Amsterdam

1994 Certification National Board of General Practitioners

1990 MD (cum laude)

 

Side Activities

  • Scientific director of the Parelsnoer Institute (PSI)

    National coordinator of the European Reference Network (ERN) Rare Endocrine Conditions

    Member of the daily board of BijnierNET

    Board member Dutch Society of Endrocrinology

Research Output (163)

ENDOCRINOLOGY IN THE TIME OF COVID-19:Clinical management of neuroendocrine neoplasms (NENs)

Casey Ruth T, Valk Gerlof D, Schalin-Jäntti Camilla, Grossman Ashley B, Thakker Rajesh V aug 2020, In: European Journal of Endocrinology. 183 , p. G79-G88

HEREDITARY ENDOCRINE TUMOURS:CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives

Pieterman C R C, Sadowski S M, Maxwell J E, Katz M H G, Lines K E, Heaphy C M, Tirosh A, Blau J E, Perrier N D, Lewis M A, Metzcar J P, Halperin D M, Thakker R V, Valk G D aug 2020, In: Endocrine-Related Cancer. 27 , p. T9-T25

PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy

Mohan Vineet, Vogel Wouter V, Valk Gerlof D, de Boer Jan P, Lam Marnix G E H, de Keizer Bart 4 jul 2020, In: Molecular Imaging. 19 7 p.

Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1:a systematic review of literature

Sadowski S M, Pieterman C R C, Perrier N D, Triponez F, Valk G D jun 2020, In: Endocrine-Related Cancer. 27 , p. R145-R161

Correction to:Correction to: Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice (World journal of surgery (2019) 43 10 (2459-2468))

Vorselaars Wessel M.C.M., van Beek Dirk Jan, Postma Emily L., Spiering Wilko, Rinkes Inne H.M.Borel, Valk Gerlof D., Vriens Menno R., Engelsman Anton F., Nieveen van Dijkum Els J.M., jan 2020, In: World Journal of Surgery. 44 , p. 323 1 p.

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas:A Systematic Review

van den Broek Medard F M, van Nesselrooij Bernadette P M, Verrijn Stuart Annemarie A, van Leeuwaarde Rachel S, Valk Gerlof D 10 dec 2019, In: Frontiers in Endocrinology. 10 16 p.

Reply to:Assessing outcomes after adrenalectomy for unliateral primary aldosteronism

Vorselaars Wessel M.C.M., van Beek Dirk Jan, Postma Emily L., Spiering Wilko, Borel Rinkes Inne H.M., Valk Gerlof D., Vriens Menno R., 1 dec 2019, In: Surgery (United States). 166 , p. 1200-1201 2 p.

Prognostic factors and survival in MEN1 patients with gastrinomas:Results from the DutchMEN study group (DMSG)

van Beek Dirk-Jan, Nell Sjoerd, Pieterman Carolina R C, de Herder Wouter W, van de Ven Annenienke C, Dekkers Olaf M, van der Horst-Schrivers Anouk N, Drent Madeleine L, Bisschop Peter H, Havekes Bas, Borel Rinkes Inne H M, Vriens Menno R, Valk Gerlof D 1 nov 2019, In: Journal of Surgical Oncology. 120 , p. 966-975 10 p.

Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice

Vorselaars Wessel M.C.M., van Beek Dirk Jan, Postma Emily L., Spiering Wilko, Borel Rinkes Inne H.M., Valk Gerlof D., Vriens Menno R., Zarnegar Rasa, Fahey Thomas J., Drake Frederick T., Duh Quan Y., Talutis Stephanie D., McAneny David B., McManus Catherine, Lee James A., Grant Scott B., Grogan Raymon H., Romero Arenas Minerva A., Perrier Nancy D., Peipert Benjamin J., Mongelli Michael N., Castelino Tanya, Mitmaker Elliot J., Parente David N., Pasternak Jesse D., Sidhu Stan B., Sywak Mark, D’Amato Gerardo, Raffaelli Marco, Schuermans Valerie, Bouvy Nicole D., Eker Hasan H., Bonjer H. Jaap, Engelsman Els J.M.Anton F., van Dijkum Nieveen, Metman Madelon J.H., Kruijff Schelto, okt 2019, In: World Journal of Surgery. 43 , p. 2459-2468 10 p.

Publisher Correction:Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)

Cejas Paloma, Drier Yotam, Dreijerink Koen M A, Brosens Lodewijk A A, Deshpande Vikram, Epstein Charles B, Conemans Elfi B, Morsink Folkert H M, Graham Mindy K, Valk Gerlof D, Vriens Menno R, Castillo Carlos Fernandez-Del, Ferrone Cristina R, Adar Tomer, Bowden Michaela, Whitton Holly J, Da Silva Annacarolina, Font-Tello Alba, Long Henry W, Gaskell Elizabeth, Shoresh Noam, Heaphy Christopher M, Sicinska Ewa, Kulke Matthew H, Chung Daniel C, Bernstein Bradley E, Shivdasani Ramesh A 9 sep 2019, In: Nature Medicine. 25 , p. 1627 1 p.

All Research Output (163)